Renewed SSC Funding Fails To Eliminate Physicists' Concerns

Although funding has been restored for the superconducting supercollider, the skies have not cleared over the Dallas-based project, as well-founded fears of another budget wrangle next year persist, say SSC officials. The Senate voted on August 3 in favor of continued SSC funding after the House voted the project down on June 17, but physicists associated with the SSC say they are still wary. They are concerned over a Congress that will have as many as 130 new members after this fall's election

Written byScott Veggeberg
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Although funding has been restored for the superconducting supercollider, the skies have not cleared over the Dallas-based project, as well-founded fears of another budget wrangle next year persist, say SSC officials. The Senate voted on August 3 in favor of continued SSC funding after the House voted the project down on June 17, but physicists associated with the SSC say they are still wary. They are concerned over a Congress that will have as many as 130 new members after this fall's election and of a possible new president, Bill Clinton, whose vice presidential running mate, Sen. Al Gore, has in the past voted against the SSC. This wariness has already resulted in reduced morale and in difficulties in attracting foreign money and collaborations, as well as new scientists for the SSC lab itself, scientists say.

"It was a rough summer on people," says SSC director Roy Schwitters. And despite ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies